Perigon Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $387K | Sell |
|
|||||
|
2025
Q2 | $368K | Sell |
|
|||||
|
2025
Q1 | $398K | Buy |
|
|||||
|
2024
Q4 | $338K | Buy |
|
|||||
|
2024
Q3 | $394K | Sell |
|
|||||
|
2024
Q2 | $401K | Buy |
|
|||||
|
2024
Q1 | $424K | Buy |
|
|||||
|
2023
Q4 | $318K | Buy |
|
|||||
|
2023
Q3 | $306K | Sell |
|
|||||
|
2023
Q2 | $312K | Buy |
|
|||||
|
2023
Q1 | $282K | Buy |
|
|||||
|
2022
Q4 | $239K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $292K | Buy |
|
|||||
|
2021
Q3 | $247K | Sell |
|
|||||
|
2021
Q2 | $269K | Buy |
|
|||||
|
2021
Q1 | $225K | Buy |
|
|||||
|
2020
Q4 | $77K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $259K | Sell |
|
|||||
|
2018
Q2 | $264K | Sell |
|
|||||
|
2018
Q1 | $261K | Hold |
|
|||||
|
2017
Q4 | $236K | Sell |
|
|||||
|
2017
Q3 | $598K | Sell |
|
|||||
|
2017
Q2 | $2.18M | Sell |
|
|||||
|
2017
Q1 | $2.15M | Buy |
|
|||||
|
2016
Q4 | $1.9M | Buy |
|
|||||
|
2016
Q3 | $1.88M | Buy |
|
|||||
|
2016
Q2 | $1.69M | Buy |
|
|||||
|
2016
Q1 | $1.59M | Hold |
|
|||||
|
2015
Q4 | $499K | Sell |
|
|||||
|
2015
Q3 | $487K | Sell |
|
|||||
|
2015
Q2 | $557K | Buy |
|
|||||
|
2015
Q1 | $497K | Buy |
|
|||||
|
2014
Q4 | $432K | Buy |
|
|||||
|
2014
Q3 | $460K | Buy |
|
|||||
|
2014
Q2 | $473K | Buy |
|
|||||
|
2014
Q1 | $285K | Hold |
|
|||||
|
2013
Q4 | $284K | Buy |
|